Clinical Trial Update: Busulfan-fludarabine Conditioning and T-cell Depleted Allogeneic Stem Cell Transplantation for Patients With Advanced Hematologic Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This update reports phase 1/2 results for busulfan-fludarabine conditioning followed by T-cell depleted allogeneic stem cell transplantation in patients with ad…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma

Drugs mentioned

• BUSULFAN (Busulfan)
• Fludarabine (Fludarabine)

Snippet

Sponsor: University of Chicago | Conditions: Leukemia, Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2019-02-04